Depletion of myocardial glucose is observed during endotoxemic but not hemorrhagic shock in a porcine model

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Chew, Michelle S ^a,d   Shekar, Kiran ^b   Brand, Björn A ^a   Norin, Carl ^a   Barnett, Adrian G ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Endotoxemia; Hemorrhage; Metabolism; Microdialysis; Myocardium; Sepsis; Shock

Indexed keywords

GLUCOSE; LACTIC ACID; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DEPLETION; ECHOCARDIOGRAPHY; ENDOTOXEMIA; FEMALE; GLUCOSE METABOLISM; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HEMORRHAGIC SHOCK; IN VIVO STUDY; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; MICRODIALYSIS; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; SEPTIC SHOCK; SKELETAL MUSCLE; ANIMAL; DISEASE MODEL; ECHOGRAPHY; METABOLISM; RANDOMIZATION; SWINE;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; FEMALE; GLUCOSE; MYOCARDIUM; RANDOM ALLOCATION; SHOCK, HEMORRHAGIC; SWINE;

EID: 84880942599     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12843     Document Type: Article

References (21)

1. Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007, 35:1599-1608. 10.1097/01.CCM.0000266683.64081.02, 17452940.
2. Fernandes CJ, de Assuncao MS. Myocardial dysfunction in sepsis: a large, unsolved puzzle. Crit Care Res Pract 2012, 896430. 2012.
3. Schwartz GG, Schaefer S, Meyerhoff DJ, Gober J, Fochler P, Massie B, Weiner MW. Dynamic relation between myocardial contractility and energy metabolism during and following brief coronary occlusion in the pig. Circ Res 1990, 67:490-500. 10.1161/01.RES.67.2.490, 2376083.
4. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997, 33:243-257. 10.1016/S0008-6363(96)00245-3, 9074687.
5. Dhainaut JF, Huyghebaert MF, Monsallier JF, Lefevre G, Dall'Ava-Santucci J, Brunet F, Villemant D, Carli A, Raichvarg D. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987, 75:533-541. 10.1161/01.CIR.75.3.533, 3815765.
6. Spitzer JJ, Bechtel AA, Archer LT, Black MR, Hinshaw LB. Myocardial substrate utilization in dogs following endotoxin administration. Am J Physiol 1974, 227:132-136.
7. Tessier JP, Thurner B, Jungling E, Luckhoff A, Fischer Y. Impairment of glucose metabolism in hearts from rats treated with endotoxin. Cardiovasc Res 2003, 60:119-130. 10.1016/S0008-6363(03)00320-1, 14522413.
8. Chew MS, Johansson A, Anderson C, Ersson A, Tonnesen E. Decreases in myocardial glucose and increases in pyruvate but not ischaemia are observed during porcine endotoxaemia. Acta Anaesthesiol Scand 2008, 52:959-968. 10.1111/j.1399-6576.2008.01603.x, 18494850.
9. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005, 365:871-875. 10.1016/S0140-6736(05)71045-X, 15752531.
10. Parrillo JE. The cardiovascular pathophysiology of sepsis. Annu Rev Med 1989, 40:469-485. 10.1146/annurev.me.40.020189.002345, 2658761.
11. Taegtmeyer H, Wilson CR, Razeghi P, Sharma S. Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 2005, 1047:208-218. 10.1196/annals.1341.019, 16093498.
12. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev 2002, 7:115-130. 10.1023/A:1015320423577, 11988636.
13. Mutschler DK, Eriksson MB, Wikstrom BG, Lind L, Larsson A, Bergren-Kiiski R, Lagrange A, Nordgren A, Basu S. Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 2003, 31:1780-1785. 10.1097/01.CCM.0000075740.61294.a6, 12794420.
14. Hauser CJ. Preclinical models of traumatic, hemorrhagic shock. Shock 2005, 24:24-32. 10.1097/01.shk.0000191387.18818.43, 16374369.
15. Schwaiger M, Neese RA, Araujo L, Wyns W, Wisneski JA, Sochor H, Swank S, Kulber D, Selin C, Phelps M, Schelbert HR, Fishbein MC, Gertz EW, Hansen H. Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium. J Am Coll Cardiol 1989, 13:745-754. 10.1016/0735-1097(89)90621-9, 2918181.
16. Runnman EM, Lamp ST, Weiss JN. Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux. J Clin Invest 1990, 86:1222-1233. 10.1172/JCI114828, 296852, 2170448.
17. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 1998, 273:29530-29539. 10.1074/jbc.273.45.29530, 9792661.
18. Mallet RT, Sun J, Knott EM, Sharma AB, Olivencia-Yurvati AH. Metabolic cardioprotection by pyruvate: recent progress. Exp Biol Med 2005, 230:435-443. (Maywood).
19. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose-fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, 1:785-789.
20. Levy B, Mansart A, Montemont C, Gibot S, Mallie JP, Regnault V, Lecompte T, Lacolley P. Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock. Intensive Care Med 2007, 33:495-502. 10.1007/s00134-006-0523-9, 17242933.
21. Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock 2008, 30:417-421. 10.1097/SHK.0b013e318167378f, 18323749.